Delivery Order SPE2DB24D1201-SPE2DB25FJEFN
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,087.92 to AmerisourceBergen Drug Corp for Menveo A-C-Y-W Kit (2 vials) on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $6,042.96 to AmerisourceBergen Drug Corp for the supply of Menveo A-C-Y-W Kit (2 vials) on September 2, 2025, with an ultimate completion date of September 3, 2025. This competitively awarded contract utilizes firm fixed-price pricing with no set-aside designation. The pharmaceutical distributor will perform this delivery from its corporate office in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,678.60 to AmerisourceBergen Drug Corp for the supply of Menveo A-C-Y-W Kit (2 vials), a meningococcal vaccine product. The contract, executed on July 14, 2025, with an ultimate completion date of July 15, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a $2,014.32 delivery order to AmerisourceBergen Drug Corp for Menveo A-C-Y-W Kit (2 vials), a meningococcal vaccine product. This firm fixed-price delivery order was competitively awarded without set-aside designation and is due for completion by August 6, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order, this delivery is executed under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,342.88 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Menveo A-C-Y-W Kit (2 Vials), a meningococcal conjugate vaccine. This firm fixed price, non-set-aside contract is scheduled for completion by September 8, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $18,912.60 delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Menveo 1 Vial A-C-Y-W-135 DIP 0.5mL, a meningococcal vaccine product. This firm fixed-price contract, with a completion date of June 3, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract was competitively...
- The Defense Logistics Agency awarded a delivery order valued at $1,007.16 to AmerisourceBergen Drug Corp for the supply of Menveo A-C-Y-W vaccine kits (2 vials each). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by July 24, 2025. The order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's corporate headquarters location. This delivery order is issued under...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $34,059.20 on August 29, 2025, for supply of Menveo A-C-Y-W Kit (2 Vials), a meningococcal vaccine product. This competitively awarded, firm fixed-price delivery order is funded by the Defense Logistics Agency Medical Supply Chain, a defense agency component, with an ultimate completion date of September 2, 2025. The contract specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $2,138.48 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Menveo A-C-Y-W vaccine kits (2 vials). This firm fixed-price, non-set-aside contract is scheduled for completion by September 5, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a routine pharmaceutical procurement under the company's existing relationship with the federal government's medical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,664.99 for Menveo 1 vial (A-C-Y-W-135-DIP 0.5ML), a meningococcal conjugate vaccine. The contract was competitively awarded without set-aside designation and is scheduled for completion by August 14, 2025. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026,...
- SPE2DB24D1201Indefinite Delivery Contract
- SPE2DB24D1201-SPE2DB25FJEFNDelivery Order
The Defense Logistics Agency awarded a $6.38K delivery order to AmerisourceBergen Drug Corp for Menveo A-C-Y-W vaccine kits (2 vials) on September 17, 2025, with completion targeted for September 18, 2025. This competitively awarded, firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99M and extending through December 2026. The prime IDC serves as a comprehensive pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contractor, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor serving military and veteran healthcare systems. The delivery order fulfills federal medical supply requirements for Menveo vaccine, a combination meningococcal vaccine used for immunization against meningitis. AmerisourceBergen's extensive portfolio of federal contract awards demonstrates its capability to meet diverse military healthcare needs across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and specialized medical supplies. The contract carries no set-aside designation, reflecting AmerisourceBergen's competitive standing within open federal procurement processes. The company's DLA relationship positions it as a key provider within the military healthcare supply chain, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.4k | 9/17/25 |